CARIS LIFE SCIENCES
Live / Applied — First extension granted (statement of use) (as of 17 Mar 2026)
What this means for you
Not registered yet, but its 16 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99000412
- Mark type
- Design + words
- Filed
- 16 Jan 2025
- Published for opposition
- 12 Aug 2025
- Attorney of record
- Anne Fleeson
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, next-generation sequencing, whole exome sequencing, whole transcriptome sequencing, whole genome sequencing, mass spectrometry, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; Medical research laboratory services; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, including screening and early detection, prognosis, and predicting or monitoring residual disease, recurrence and/or therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes
- Class 044 — Medical, beauty and agricultural services: medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services
Owner
- Caris MPI, Inc., Irving, TX, US
- Caris MPI, Inc., Irving, TX, US
Prosecution history
- 18 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2026 — SOU EXTENSION 1 GRANTED
- 17 Mar 2026 — SOU EXTENSION 1 FILED
- 17 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Aug 2025 — PUBLISHED FOR OPPOSITION
- 06 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Jul 2025 — EXAMINER'S AMENDMENT ENTERED
- 02 Jul 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Jul 2025 — EXAMINERS AMENDMENT E-MAILED
- 02 Jul 2025 — EXAMINERS AMENDMENT -WRITTEN
- 30 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Jun 2025 — NON-FINAL ACTION E-MAILED